SMARCA4/BRG1 protein-deficient thoracic tumors dictate re-examination of small biopsy reporting in non–small cell lung cancer

BACKGROUND: SMARCA4/BRG1 protein–deficient lung adenocarcinomas and thoracic sarcoma are recently described entities that lack distinctive histological features, transcription termination factor 1 (TTF1) reactivity, and actionable driver mutations. The current diagnostic path for small lung biopsies...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Anurag, Bansal, Divya, Tripathi, Rupal, Jajodia, Ankush
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pathologists/The Korean Society for Cytopathology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476316/
https://www.ncbi.nlm.nih.gov/pubmed/34147056
http://dx.doi.org/10.4132/jptm.2021.05.11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476316/
https://www.ncbi.nlm.nih.gov/pubmed/34147056
http://dx.doi.org/10.4132/jptm.2021.05.11

Ejemplares similares